GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RIV Capital Inc (XCNQ:RIV) » Definitions » Operating Margin %

RIV Capital (XCNQ:RIV) Operating Margin % : -269.34% (As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is RIV Capital Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. RIV Capital's Operating Income for the three months ended in Sep. 2023 was C$-6.18 Mil. RIV Capital's Revenue for the three months ended in Sep. 2023 was C$2.30 Mil. Therefore, RIV Capital's Operating Margin % for the quarter that ended in Sep. 2023 was -269.34%.

The historical rank and industry rank for RIV Capital's Operating Margin % or its related term are showing as below:

XCNQ:RIV' s Operating Margin % Range Over the Past 10 Years
Min: -707.84   Med: -619.23   Max: -69.69
Current: -276.37


XCNQ:RIV's Operating Margin % is ranked worse than
91.08% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 6.075 vs XCNQ:RIV: -276.37

RIV Capital's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

RIV Capital's Operating Income for the three months ended in Sep. 2023 was C$-6.18 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2023 was C$-26.52 Mil.


RIV Capital Operating Margin % Historical Data

The historical data trend for RIV Capital's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RIV Capital Operating Margin % Chart

RIV Capital Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22
Operating Margin %
- -619.23 -69.69 -707.84 -

RIV Capital Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -202.99 -221.01 -354.86 -264.73 -269.34

Competitive Comparison of RIV Capital's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, RIV Capital's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RIV Capital's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RIV Capital's Operating Margin % distribution charts can be found below:

* The bar in red indicates where RIV Capital's Operating Margin % falls into.



RIV Capital Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

RIV Capital's Operating Margin % for the fiscal year that ended in Mar. 2022 is calculated as

Operating Margin %=Operating Income (A: Mar. 2022 ) / Revenue (A: Mar. 2022 )
=-18.014 / 0
= %

RIV Capital's Operating Margin % for the quarter that ended in Sep. 2023 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=-6.184 / 2.296
=-269.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RIV Capital  (XCNQ:RIV) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


RIV Capital Operating Margin % Related Terms

Thank you for viewing the detailed overview of RIV Capital's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


RIV Capital (XCNQ:RIV) Business Description

Traded in Other Exchanges
Address
40 King Street West, Suite 2504, Toronto, ON, CAN, M5H 3Y2
RIV Capital Inc is a venture capital investment and operating platform structured to pursue investment opportunities in the cannabis sector. The company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the cannabis sector. The investments take the form of production-linked royalties, secured debt, newly formed joint ventures, and a variety of equity and equity-linked instruments.